EGF and neoplasm: The BBB-targeted EGF peptide radiopharmaceutical shown in Figure 14A enabled brain imaging of an intra-cranial human glial tumor in the nude rats, as shown in Figure 14B. The over-expression of the tumor EGFR was confirmed by immunohistochemistry of the tumor at post-mortem (Figure 14C).